Puerarin-4'-O-β-D-glucopyranoside

Catalog No. :
ACVZOL999
CAS No. :
117047-08-2
Molecular Formula :
C27H30O14
Molecular Weight :
578.52

IUPAC Name:Puerarin-4'-O-β-D-glucopyranoside

Puerarin-4'-O-β-D-glucopyranoside structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
10mg98%$309.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NamePuerarin-4'-O-β-D-glucopyranoside
IUPAC NamePuerarin-4'-O-β-D-glucopyranoside
MDL No.MFCD34469515
Molecular FormulaC27H30O14
Molecular Weight578.52
SMILESOC1=CC=C2C(C(C3=CC=C(C=C3)O[C@@H]4O[C@H](CO)[C@H]([C@@H]([C@H]4O)O)O)=COC2=C1[C@@H]5O[C@H](CO)[C@H]([C@@H]([C@H]5O)O)O)=O
InChI KeyGZFMKWZQYRIRBD-WIQAIWCDSA-N
SynonymPuerarin-4'-O-β-D-glucopyranoside;4H-1-Benzopyran-4-one, 8-β-D-glucopyranosyl-3-[4-(β-D-glucopyranosyloxy)phenyl]-7-hydroxy-;Puerarin Impurity 4;Puerarin-4′-O-β-D-glucopyranoside;Puerarin4'-O-glucoside;lobata,anti-proliferation,carcinoma,Inhibitor,PLR,Isoflavone,Puerarin 4' O β D glucopyranoside,MCF-7,estrogenic,root,Puerarin4'OβDglucopyranoside,Pueraria,activity,human,breast,inhibit;Puerarin-4'-O-D-glucoside;Puerarin-4''-O-β-D-glucopyranoside
CAS No.117047-08-2

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACVZOL999 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACVZOL999 route product structure diagram
    ACVZOL999117047-08-2
Inquiry

2. ACVZOL999 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACVZOL999 route product structure diagram
    ACVZOL999117047-08-2
Inquiry

Comments (0)